Thomas E. Hutson, DO, PharmD, and David F. McDermott, MD, assess adjuvant therapy strategies in individuals with renal cell carcinoma at high risk of recurrence. View Now >>
Led by moderator Mark A. Socinski, MD, panelists Mary Jo Fidler, MD; Roy S. Herbst, MD, PhD; and Geoffrey R. Oxnard, MD, discuss ASCO 2015 data on ADZ9291 and rociletinib, which continue to show impressive efficacy and safety profiles. View Now >>
Featured Program
Giants of Cancer Care
The OncLive News Network updates viewers on breaking news, clinical trial results, FDA approvals, and offers an inside look into leading cancer centers and clinical trials. View Now >>
Highlights from the 2014 ASH Annual Meeting
Laura Jones recaps major findings from the 2015 ASCO Annual Meeting, including phase III findings for new treatments in melanoma, chronic lymphocytic leukemia, lung cancer, breast cancer, and multiple myeloma.
View Now

Most Popular Right Now
$auto_registration$